Tuyen Ong

Tuyen Ong is a CEO-Partner at Flagship Pioneering and the Chief Executive Officer of Ring Therapeutics, currently based in Cambridge, Massachusetts. Appointed to these dual leadership roles on October 14, 2020, he directs venture creation and enterprise strategy for the larger biotechnology venture investment firm. At Ring Therapeutics, a specialized gene therapy company originally founded by the internal innovation foundry Flagship Labs, Ong oversees the strategic development of novel genetic medicines and treatments. As a physician holding an M.D., he leverages his extensive clinical expertise to drive long-term value creation and serves on the board of directors for several distinct portfolio companies across the Flagship ecosystem. His professional background centers on life sciences innovation, biotechnology company building, and the operational execution required to advance complex therapeutic platforms from early-stage scientific research into viable clinical applications.